 |
|
Gladstone scientists identify single microRNA that controls blood vessel development
August 12, 2008Provides potential therapeutic target for a number of diseases
Scientists from the Gladstone Institute of Cardiovascular Disease (GICD) and UCSF have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins, and capillaries that allow blood to reach all tissues and organs. The research, published in the latest issue of Developmental Cell, may offer clues to potential therapeutic targets for a wide variety of diseases, such as heart disease or cancer, that are impacted by or affect the vascular system.
Researchers in laboratory of GICD Director Deepak Srivastava, MD, found that microRNA (miR-126), a tiny RNA molecule, is intimately involved in the response of blood vessels to angiogenic signals. Angiogenesis, the process of vascular development, is a tightly regulated and well-studied process.A cascade of genes orchestrate a series of events leading to formation of blood vessels in an embryo.
"Some of these same gene regulatory networks are re-activated in the adult to direct the growth of new blood vessels" said Jason Fish, PhD, lead author of the study. "This can be beneficial, as in the case of a heart attack."
Blood vessel formation can also contribute to disease in settings like cancer, where vessels feed a growing tumor.
"Finding that a single factor regulates a large part of the angiogenic process creates a significant target for therapeutic development for any disease involving the vascular system," said Dr. Srivastava. "The next step is to find ways to modify this microRNA in the setting of disease and test its ability to alter the disease process."
Researchers examined cells, called endothelial cells, that line the lumen or inside of blood vessels. Once the vascular endothelial cells adopt their fate during development, they come together to form cord-like structures that are remodeled to become lumenized blood vessels. In adults, angiogenic signals, such as vascular endothelial growth factor (VEGF), activate endothelial cells and cause them to form new blood vessels. Individual microRNAs, which titrate the level of specific proteins generated by the cell, were not previously known to affect VEGF signaling or regulate angiogenesis.
The team used three model systems. First, they looked for microRNAs that were enriched in endothelial cells from mouse embryonic stem (ES) cells. They found that miR-126 was the most abundant in and most specific for endothelial cells. They next investigated the function of miR-126 in cultured human endothelial cells and found that this microRNA was involved in the structure, migration, proliferation and survival of endothelial cells. Third, they turned to the zebrafish system to investigate the in vivo function of miR-126 for three reasons. (1) It is a tractable system for perturbing microRNA levels and examining the consequences in a live organism. (2) The developing fish does not require a functioning cardiovascular system to survive through the initial stages of development. (3) The embryos are transparent and can be easily and directly visualized as they are developing. Loss of miR-126 function did not affect the initial patterning of the vascular network, but blood vessels subsequently collapsed and considerable internal bleeding occurred, illustrating the requirement of miR-126 for normal vessel formation and maintenance.
Researchers also found that miR-126 regulated endothelial responses to angiogenic signals by regulating several components of the VEGF pathway, which is important during development of blood vessels and is required for their maintenance. miR-126 repressed the actions of the Sprouty-related protein, SPRED1, and phosphoinositol-3 kinase regulatory subunit 2 both negative regulators of VEGF signals.
They replicated the effects of the loss of miR-126 by increasing expression of Spred1 or inhibiting VEGF signaling. Thus, miR-126 normally promotes vessel formation and stability by "repressing the repressors" of VEGF signaling. Since inhibiting VEGF signaling has been a major target of modern cancer therapies, regulating miR-126 represents an additional approach to regulate blood vessel formation in such diseases.
Gladstone Institutes
"Some of these same gene regulatory networks are re-activated in the adult to direct the growth of new blood vessels" said Jason Fish, PhD, lead author of the study. "This can be beneficial, as in the case of a heart attack."
Blood vessel formation can also contribute to disease in settings like cancer, where vessels feed a growing tumor.
"Finding that a single factor regulates a large part of the angiogenic process creates a significant target for therapeutic development for any disease involving the vascular system," said Dr. Srivastava. "The next step is to find ways to modify this microRNA in the setting of disease and test its ability to alter the disease process."
Researchers examined cells, called endothelial cells, that line the lumen or inside of blood vessels. Once the vascular endothelial cells adopt their fate during development, they come together to form cord-like structures that are remodeled to become lumenized blood vessels. In adults, angiogenic signals, such as vascular endothelial growth factor (VEGF), activate endothelial cells and cause them to form new blood vessels. Individual microRNAs, which titrate the level of specific proteins generated by the cell, were not previously known to affect VEGF signaling or regulate angiogenesis.
The team used three model systems. First, they looked for microRNAs that were enriched in endothelial cells from mouse embryonic stem (ES) cells. They found that miR-126 was the most abundant in and most specific for endothelial cells. They next investigated the function of miR-126 in cultured human endothelial cells and found that this microRNA was involved in the structure, migration, proliferation and survival of endothelial cells. Third, they turned to the zebrafish system to investigate the in vivo function of miR-126 for three reasons. (1) It is a tractable system for perturbing microRNA levels and examining the consequences in a live organism. (2) The developing fish does not require a functioning cardiovascular system to survive through the initial stages of development. (3) The embryos are transparent and can be easily and directly visualized as they are developing. Loss of miR-126 function did not affect the initial patterning of the vascular network, but blood vessels subsequently collapsed and considerable internal bleeding occurred, illustrating the requirement of miR-126 for normal vessel formation and maintenance.
Researchers also found that miR-126 regulated endothelial responses to angiogenic signals by regulating several components of the VEGF pathway, which is important during development of blood vessels and is required for their maintenance. miR-126 repressed the actions of the Sprouty-related protein, SPRED1, and phosphoinositol-3 kinase regulatory subunit 2 both negative regulators of VEGF signals.
They replicated the effects of the loss of miR-126 by increasing expression of Spred1 or inhibiting VEGF signaling. Thus, miR-126 normally promotes vessel formation and stability by "repressing the repressors" of VEGF signaling. Since inhibiting VEGF signaling has been a major target of modern cancer therapies, regulating miR-126 represents an additional approach to regulate blood vessel formation in such diseases.
Gladstone Institutes
Endothelial Cells Current Events and Endothelial Cells News RSSStudy shows direct link between leptin and obesity-related cardiovascular disease
Obese people who don't have high cholesterol or diabetes might think they're healthy - despite the extra pounds.
Yale researchers unravel mystery of brain aneurysms
Yale researchers have taken the first critical steps in unraveling the mysteries of brain aneurysms, the often fatal rupturing of blood vessels that afflicts 500,000 people worldwide each year and nearly killed Vice President-elect Joseph Biden two decades ago.
Cancer drugs my build and not tear down blood vessels
Scientists have thought that one way to foil a tumor from generating blood vessels to feed its growth - a process called angiogenesis - was by creating drugs aimed at stopping a key vessel growth-promoting protein. But now the opposite seems to be true.
Building the blood-brain barrier
Construction of the brain's border fence is supervised by Wnt/b-catenin signaling, report Liebner et al. in The Journal of Cell Biology.
Vulnerable plaque may be easier to detect through new imaging technology
Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Healthy blood vessels may prevent fat growth
The cells lining blood vessels are known to be important for maintaining health, but researchers at the Indiana University School of Medicine believe these cells may perform an unsuspected task - controlling the development of fat cells.
New drug substantially extends survival in pancreatic cancer
A new form of chemotherapy that destroys new blood vessels that grow around tumors has produced excellent results in a phase II trial of patients with inoperable pancreatic cancer, researchers report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs
Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells.
Study reveals how blood flow force prevents clogged arteries
Machines on cell surfaces, mechanical and lifeless as bed springs, protect blood vessels by responding to blood flow force, according to research published today in the Journal of Cell Biology.
Normalizing tumor vessels to improve cancer therapy
Chemotherapy drugs often never reach the tumors they're intended to treat, and radiation therapy is not always effective, because the blood vessels feeding the tumors are abnormal-"leaky and twisty" in the words of the late Judah Folkman, MD, founder of the Vascular Biology program at Children's Hospital Boston.
More Endothelial Cells Current Events and Endothelial Cells News Articles
 | Methods in Endothelial Cell Biology (Springer Lab Manuals) Endothelial cell biology has developed into a vibrant discipline and has become a critical instrument to study several disease processes on the cellular and molecular level. It is now widely recognized that dysfunctions of normal endothelial cell homeostasis are involved in some of the most important human diseases, including ischemic heart diseases, hypertension, atherosclerosis, tumors,... |
 | Endothelial Cells in Health and Disease This reference serves as the first source to gather current data from endothelial cell biologists in various disciplines to summarize recent progress in the field-providing a complete understanding of the endothelium in health and disease and demonstrating its potential as a therapeutic... |
 | Endothelial Biomedicine The endothelium, the cell layer that forms the inner lining of blood vessels, is a spatially distributed system that extends to all reaches of the human body. Today, clinical and basic research demonstrates that the endothelium plays a crucial role in mediating homeostasis and is involved in virtually every disease, either as a primary determinant of pathophysiology or as a victim of collateral... |
 | Endothelial Cell Culture (Handbooks in Practical Animal Cell Biology) Endothelial Cell Culture contains chapters by experts on endothelial cells derived from the lung, bone marrow, brain, mammary glands, skin, adipose tissue, female reproductive system, and... |
| Endothelial Cell Biology in Health and Disease | |
| Structure and Function of Endothelial Cells by Bodensee Symposium on Microcirculation | |
| Studies on Effects of Antioxidants on Arterial Thrombosis and Endothelial Cell Injury: With Special Reference to Tocopherols and Apoa1 Milano (Comprehensive Summaries of Uppsala Dissertations, 936) by Dayuan Li | |
| Endothelial Cell Dysfunction in Diabetes | |
| Signal Transduction in Human Endothelial Cells and Endothelial Cell and Platelet Activation in Vivo in Man by C. Van Geet | |
 | Hypoxia-induced expression of HIF-1@a and its target genes in umbilical venous endothelial cells of Tibetans and immigrant Han [An article from: Comparative Biochemistry and Physiology, Part C] by W. Gao, Y. Gao, G. Zhang, L. Song, B. Sun, J. Shi This digital document is a journal article from Comparative Biochemistry and Physiology, Part C, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: The better adaptation of native Tibetans to hypoxia is thought to be partly due to improved umbilical... |
| © 2008 BrightSurf.com |